Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00314691
Status:
TERMINATED
Last Update Posted:
2011-07-28
First Post:
2006-04-12
Brief Title:
Development of New Prenatal Diagnostic Tests From Maternal Blood
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Development of New Prenatal Diagnostic Tests From Maternal Blood
Status:
TERMINATED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Leaving of the person responsible for the data collection
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
After extraction of the cell-free DNA circulating in maternal plasma we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination and indirect diagnosis of inherited diseases like Cystic Fibrosis Huntington Disease Myotonic Dystrophy B-Thalassaemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None